SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease 13/10/2026
Translumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices, Netherlands 22/07/2026
Translumina Therapeutics, India’s largest domestic player in the coronary stents market, announces the initiation of direct operations in the UAE 22/07/2026
